![Thomas Raueiser](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Raueiser
Director/Miembro de la Junta en Abalos Therapeutics GmbH .
Perfil
Thomas Raueiser has worked as a Director at Abalos Therapeutics GmbH and as a Senior Investment Manager at NRW.Bank (Private Equity).
Cargos activos de Thomas Raueiser
Empresas | Cargo | Inicio |
---|---|---|
NRW.Bank (Private Equity)
![]() NRW.Bank (Private Equity) Investment ManagersFinance NRW.Bank (Private Equity) (NRWB PE) is the private equity operating division of the NRW Bank which traces their origins to 2002 when Westdeutsche Landesbank Girozentrale was split up into two entities. From this basis and further to the 2004 Reorganization Act, the current foundations for NRW Bank were established. Headquartered in Dusseldorf, Germany, NRWB PE specializes in providing capital and business development support for SMEs in North Rhine-Westphalia. They manage a number of private equity funds. Through mezzanine capital as a co-investor alongside lead investors, they provide equity limited to minority stakes as a silent partner. | Inversor de Capital Privado | - |
Abalos Therapeutics GmbH
![]() Abalos Therapeutics GmbH BiotechnologyHealth Technology Abalos Therapeutics GmbH engages in the development of an anti-cancer arenavirus-based drug. It focuses on awakening immune responses against tumors and metastases. The company was founded by Karl Lang and Philipp Lang and is headquartered in Essen, Germany. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
NRW.Bank (Private Equity)
![]() NRW.Bank (Private Equity) Investment ManagersFinance NRW.Bank (Private Equity) (NRWB PE) is the private equity operating division of the NRW Bank which traces their origins to 2002 when Westdeutsche Landesbank Girozentrale was split up into two entities. From this basis and further to the 2004 Reorganization Act, the current foundations for NRW Bank were established. Headquartered in Dusseldorf, Germany, NRWB PE specializes in providing capital and business development support for SMEs in North Rhine-Westphalia. They manage a number of private equity funds. Through mezzanine capital as a co-investor alongside lead investors, they provide equity limited to minority stakes as a silent partner. | Finance |
Abalos Therapeutics GmbH
![]() Abalos Therapeutics GmbH BiotechnologyHealth Technology Abalos Therapeutics GmbH engages in the development of an anti-cancer arenavirus-based drug. It focuses on awakening immune responses against tumors and metastases. The company was founded by Karl Lang and Philipp Lang and is headquartered in Essen, Germany. | Health Technology |
- Bolsa de valores
- Insiders
- Thomas Raueiser